FDA — authorised 24 December 1991
- Status: approved
🇺🇸 Vantas in United States
FDA authorised Vantas on 24 December 1991
Marketing authorisations
FDA — authorised 12 October 2004
- Application: NDA021732
- Marketing authorisation holder: ENDO OPERATIONS
- Local brand name: VANTAS
- Indication: IMPLANT — SUBCUTANEOUS
- Status: approved
FDA — authorised 2 April 2013
- Application: NDA022058
- Marketing authorisation holder: ENDO OPERATIONS
- Indication: Labeling
- Status: approved
Vantas in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Vantas approved in United States?
Yes. FDA authorised it on 24 December 1991; FDA authorised it on 12 October 2004; FDA authorised it on 2 April 2013.
Who is the marketing authorisation holder for Vantas in United States?
Marketing authorisation holder not available in our data.